Remdesivir for COVID-19: Why Not Dose Higher?

被引：8

作者：

Yan, Victoria C. ^{[1
]}

Mueller, Florian L. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA

来源：

关键词：

COVID-19; GS-441524; drug metabolism; prodrug; remdesivir;

D O I：

10.1128/AAC.02713-20

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页数：3

共 50 条

[1] Reply to Yan and Muller, "Remdesivir for COVID-19: Why Not Dose Higher?"
Juneja, Kavita
Humeniuk, Rita
Porter, Danielle
Cao, Huyen
Feng, Joy
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
[2] Remdesivir and COVID-19
Francesco Ferrara
Raffaele La Porta
Vilma D’Aiuto
Antonio Vitiello
Irish Journal of Medical Science (1971 -), 2021, 190 : 1237 - 1238
[3] Remdesivir in covid-19
Ferner, Robin E.
Aronson, Jeffrey K.
BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
[4] Remdesivir and COVID-19
Wang, Lei-Yun
Cui, Jia-Jia
Ouyang, Qian-Ying
Zhan, Yan
Guo, Cheng-Xian
Yin, Ji-Ye
LANCET, 2020, 396 (10256): : 953 - 954
[5] Remdesivir and COVID-19
Ferrara, Francesco
La Porta, Raffaele
D'Aiuto, Vilma
Vitiello, Antonio
IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1237 - 1238
[6] Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola
Yan, Victoria C.
Muller, Florian L.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
[7] Remdesivir for patients with COVID-19
Wu, Peter E.
Morris, Andrew M.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (04) : E125 - E125
[8] Remdesivir bei COVID-19
Redaktion Facharztmagazine
MMW - Fortschritte der Medizin, 2022, 164 (2) : 65 - 65
[9] COVID-19: Is Remdesivir the Cure?
不详
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (13)
[10] Remdesivir (Veklury) for COVID-19
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 186 - 188